GrantQuick

consumer_protection · food_and_nutrition · agriculture · HHS-FDA

Cooperative Agreement to Support Activities Related to Analgesics, Anesthetics, and Addiction (U01) Clinical Trials Allowed

Food and Drug Administration · FOR-FD-25-009

Closed

Award Range

$2.0M$2.0M

Expected Awards

5

Deadline

TBD

GRANTQUICK SUMMARYPlain-English Overview

Cooperative Agreement to Support Activities Related to Analgesics, Anesthetics, and Addiction (U01) Clinical Trials Allowed. Food and Drug Administration. To develop, disseminate, implement, and evaluate research needed in Anesthesia, Addiction Medicine and Pain Medicine in various fields of research. Specifically, research is needed in the following fields: function as a clinical trial endpoint and measurement of function in patients with... $2,000,000-$2,000,000 per award; ~5 awards expected.

Who Should Apply

Unrestricted (any eligible entity), Nonprofits (501c3), State governments, Other Native American Tribal Organizations, Federally Recognized Native American Tribal Governments (+10 more)

Who Should NOT Apply

Few restrictions — most eligible entities can apply

Key Requirements (Plain English)

  • See full opportunity listing for requirements

💡 GrantQuick Tip

Focus your proposal on clear outcomes, alignment with agency priorities, and demonstrate organizational capacity.

Competitiveness: Very high — extremely limited awards available

What This Grant Funds

To develop, disseminate, implement, and evaluate research needed in Anesthesia, Addiction Medicine and Pain Medicine in various fields of research. Specifically, research is needed in the following fields: function as a clinical trial endpoint and measurement of function in patients with chronic pain, outcome measures for clinical trials in stimulant use disorders, assessment of opioid clinical trials with active control in addition to placebo, neurodevelopmental outcome assessment of vulnerable pediatric patients exposed to anesthesia and opioid, and a living systematic review of pre-clinical studies of anesthetic neurotoxicity. Multiple awards may be considered. Applicants must propose a comprehensive evidence-based plan that advances appropriate prescribing of drug products intended for analgesia, anesthesia, and substance use disorders.

Who Can Apply

Eligible Applicant Types

Unrestricted (open to all)501(c)(3) NonprofitsState GovernmentsOther Tribal OrganizationsFederally Recognized Tribal GovernmentsCounty GovernmentsNonprofits without 501(c)(3)Public And Indian Housing AuthoritiesSpecial District GovernmentsPrivate Colleges & UniversitiesSmall BusinessesCity/Township GovernmentsPublic Colleges & UniversitiesFor-Profit OrganizationsIndependent School Districts

Funding Details

Minimum Award
$2.0M
Maximum Award
$2.0M
Expected Number of Awards
5
Cost Sharing Required?
No
Funding Instrument
cooperative_agreement

Key Dates

Posted: August 14, 2024
Application Deadline: TBD (0 days remaining)

Agency Contact

Terrin Brown Grantor 2404027610

terrin.brown@fda.hhs.gov

Ready to apply?

View the full NOFO and submit your application on Grants.gov